Qingdao Haier Biomedical Co (SHSE:688139) Other Current Liabilities: ¥117 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688139 Qingdao Haier Biomedical Co Ltd SHSE:688139
84 GF Score
Price ¥29.54
GF Value ¥36.66
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Qingdao Haier Biomedical Co Other Current Liabilities?

Qingdao Haier Biomedical Co SHSE:688139 -1.66% 84 Other Current Liabilities is ¥117 Mil as of Jun. 2026. GuruFocus rates SHSE:688139 with a GF Score™ of 84/100 and a GF Value™ of ¥36.66 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Qingdao Haier Biomedical Co's other current liabilities for the quarter that ended in Jun. 2026 was ¥117 Mil.

Qingdao Haier Biomedical Co's quarterly other current liabilities declined from Dec. 2025 (¥187 Mil) to Mar. 2026 (¥139 Mil) and declined from Mar. 2026 (¥139 Mil) to Jun. 2026 (¥117 Mil).

Qingdao Haier Biomedical Co's annual other current liabilities increased from Dec. 2023 (¥121 Mil) to Dec. 2024 (¥163 Mil) and increased from Dec. 2024 (¥163 Mil) to Dec. 2025 (¥187 Mil).

Qingdao Haier Biomedical Co Other Current Liabilities Related Terms

Qingdao Haier Biomedical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Qingdao Haier Biomedical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qingdao Haier Biomedical Co Other Current Liabilities Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 377.74 247.19 120.53 163.38 187.32

Qingdao Haier Biomedical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.91 99.88 187.32 139.15 116.69
SHSE:688139
84GF Score
Qingdao Haier Biomedical Co Ltd SHSE:688139
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qingdao Haier Biomedical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ¥117 Mil mean?
Qingdao Haier Biomedical Co (SHSE:688139) has a Other Current Liabilities of ¥117 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Qingdao Haier Biomedical Co.
Is Qingdao Haier Biomedical Co's Other Current Liabilities too high?
Qingdao Haier Biomedical Co's current Other Current Liabilities is ¥117 Mil. Overall, Qingdao Haier Biomedical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Haier Biomedical Co's Other Current Liabilities compare to ABT and SYK?
Qingdao Haier Biomedical Co's Other Current Liabilities of ¥117 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Qingdao Haier Biomedical Co. Qingdao Haier Biomedical Co's current Other Current Liabilities is ¥117 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Haier Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co (SHSE:688139) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥36.66, compared to a current price of ¥29.54 — trading 19.4% below its estimated fair value. The current Other Current Liabilities is ¥117 Mil. Qingdao Haier Biomedical Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Qingdao Haier Biomedical Co (SHSE:688139), the current Other Current Liabilities is ¥117 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qingdao Haier Biomedical Co (SHSE:688139) Overvalued in 2026?

Based on GuruFocus' analysis, Qingdao Haier Biomedical Co stock appears to be undervalued. The current stock price of ¥29.54 is trading 19.4% below its estimated GF Value™ of ¥36.66. GuruFocus considers Qingdao Haier Biomedical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688139:

  • Other Current Liabilities: ¥117 Mil
  • GF Value™: ¥36.66 vs. price of ¥29.54 (19.4% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qingdao Haier Biomedical Co Business Description

Address No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
84GF Score

Get the complete analysis for SHSE:688139

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.54
Price
¥36.66
GF Value